News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

TopoTarget A/S and Spectrum Pharmaceuticals, Inc. (SPPI) Agree on Terms for Commercial Supply of Belinostat


10/7/2013 9:40:46 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Topotarget and Spectrum Pharmaceuticals announce an amendment to the companies’ existing License Agreement. Pursuant to the amendment, Spectrum Pharmaceuticals will carry the responsibility for the commercial manufacture of belinostat for a 5-year period with the possibility of renewal.

Help employers find you! Check out all the jobs and post your resume.

Read at GlobeNewswire

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES